Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

Comment by Enoughon Nov 10, 2021 1:00pm
143 Views
Post# 34110804

RE:RE:Another News release, and…

RE:RE:Another News release, and…
Mortimer wrote: Plenty here to be excited about, what about all the purchase orders being finalized, they talked about being in agreement with 11 hospitals in the September NR. Or the fact the the ceo sent out a letter to shareholders sayin theres more news on the way, just waiting on approvals for the NRs, isn't that a good sign?  It seems you have hopes that the sp will go down otherwise these statements would provide a reason for patience. And no, of course it's not like an electrical certificate for your car. Check the NR. It's another passed inspection of their manufacturing facility and products, more red tape behind us. Granted, it's not exactly the exloading news we're all waiting for but as GA and Peter Weichler said in their emails, they aren't able to talk about the big news yet. If you're a long term shareholder be patient, if you're a short seller cover and move on ..short squeeze is coming



I think, And others as well think, that it is reasonable to question the absence of sales, Even though, there have been mentions of potential sales in chat rooms,videos,news releases and these letters.

Remember, there is always the caveat that is mentioned that these are forward-looking Statements if you read the small print underneath the annual reports etc.

Having said that, let me ask what people think is a reasonable time to expect to see Sales come through. I don't want to appear unreasonable or impatient, but this has been a long time coming from China,waiting for alliance, till now and still no sales. What is reasonable to expect to see sales reported?
This isn't a novel tech.

If we do not establish timelines, it always becomes forward-looking. What do you think what is reasonable to expect to see the sales coming through?
<< Previous
Bullboard Posts
Next >>